MentionFox
Home › Layoffs › Aerovate Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Aerovate Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Aerovate Therapeutics, Inc.

MentionFox check on Aerovate Therapeutics, Inc.: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/aerovate-therapeutics

  • Note: Layoff plan disclosed Jul 2024 (filing)

New since last check: Layoff plan disclosed Jul 2024 (filing, first seen 14 November 2026).

Check Aerovate Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Aerovate Therapeutics, Inc.?

Every exit or restructuring plan Aerovate Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

Aerovate Therapeutics, Inc.'s latest layoff filing, on July 1, 2024, states a cut of about 78% of its workforce. As of November 14, 2026, it has reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, July 1, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Sofinnova Venture Partners X, L.P. ("SVP X") also filed stake reports on 1 other company ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Aerovate Therapeutics, Inc.

Free to see. No signup.

People from Aerovate Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Aerovate Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings2
Latest filing2024-07-01

Aerovate Therapeutics, Inc. reported 2 exit or restructuring plans on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Aerovate Therapeutics have layoffs in 2024? What its filings say

Aerovate Therapeutics, Inc. (CIK 1798749) reported 2 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K/A filed 2024-07-01

Share of workforce

The Company initiated the first wave of its Workforce Reduction Plan by notifying 39 individuals, or 78% of the Company's workforce, of their termination.

Expected charges

In connection with the Workforce Reduction Plan, the Company estimates that it will be incurring costs (in consideration of releases) of approximately $5.6 million, which are primarily one-time severance benefits.

Timing

These costs are expected to be incurred in the third and fourth quarter of 2024.

Form 8-K filed 2024-06-28

Share of workforce

The Company initiated the first wave of its Workforce Reduction Plan by notifying 39 individuals, or 78% of the Company's workforce, of their termination.

Expected charges

In connection with the Workforce Reduction Plan, the Company estimates that it will be incurring costs (in consideration of releases) of approximately $5.6 million, which are primarily one-time severance benefits.

Timing

These costs are expected to be incurred in the third and fourth quarter of 2024.

Also on the record for Aerovate Therapeutics, Inc.

DateRecordFigureOur pageSource
October 28, 2026Stake report, Schedule 13G, by Franklin Templeton, Inc.6% of the class5%+ stakesSource
October 27, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.2% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Bellevue Group AG5% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Venrock Healthcare Capital Partners III, L.P.8.3% of the class5%+ stakesSource
July 17, 2026Stake report, Schedule 13G, by Paradigm BioCapital Advisors LP5.1% of the class5%+ stakesSource
July 8, 2026Stake report, Schedule 13G/A, by JANUS HENDERSON GROUP Ltd.10.6% of the class5%+ stakesSource
June 26, 2026Leadership change: Mark Eisner appointed—Leadership changesSource
June 9, 2026Stake report, Schedule 13D/A, by Fairmount Funds Management LLC19.99% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by JANUS HENDERSON GROUP PLC6.3% of the class5%+ stakesSource
April 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.4.7% of the class5%+ stakesSource
April 22, 2026Leadership change: Andrew King appointed, President—Leadership changesSource
March 5, 2026Stake report, Schedule 13D/A, by Sofinnova Venture Partners X, L.P. ("SVP X")0.3% of the class5%+ stakesSource

Keep reading

More on Aerovate Therapeutics, Inc. and the records around it.

Aerovate Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Aerovate Therapeutics, Inc.?

Want the whole picture on Aerovate Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Aerovate Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Aerovate Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    14 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 25 records.

Tools for this story

Each opens in a new tab, filled in for Aerovate Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/aerovate-therapeutics
Last updated 2026-11-14
Aerovate Therapeutics layoffs 2024: 78% of workforce (8-K). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/aerovate-therapeutics